The protein denaturation inhibition assay is essential for evaluating the anti-inflammatory properties of plant extracts and compounds. By assessing the ability of a sample to prevent or reduce the denaturation of egg albumin, researchers can identify potential anti-inflammatory agents that stabilize protein structures, thereby mitigating inflammation and tissue damage. This assay is valuable in pharmaceutical development, natural product research, and the formulation of anti-inflammatory therapies. The assay employs egg albumin as a model protein whose denaturation is induced by heat. Anti-inflammatory agents are hypothesized to stabilize the protein structure, preventing denaturation. By measuring the extent of albumin denaturation through absorbance at 660 nm, the method provides a reliable and quantitative means to assess the inhibitory effects of the tested samples. The use of controls ensures the accuracy and reproducibility of the results, making this method both reasonable and dependable for evaluating protein stabilization and anti-inflammatory potential.